Shafaat A. Rabbani

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Molecular Biology, Oncology
Google:
"Shafaat Rabbani"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mahmood N, Arakelian A, Szyf M, et al. (2024) Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition. Experimental & Molecular Medicine
Mehdi A, Attias M, Arakelian A, et al. (2022) Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone. Cancers. 15
Mehdi A, Rabbani SA. (2021) Role of Methylation in Pro- and Anti-Cancer Immunity. Cancers. 13
Mahmood N, Arakelian A, Muller WJ, et al. (2020) An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis. Bone Research. 8: 28
Mahmood N, Arakelian A, Khan HA, et al. (2020) uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions. Bone Research. 8: 18
Mahmood N, Arakelian A, Cheishvili D, et al. (2020) S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis. Journal of Cellular and Molecular Medicine
Mahmood N, Arakelian A, Muller WJ, et al. (2020) An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis. Bone Research. 8: 28
Mehdi A, Cheishvili D, Arakelian A, et al. (2020) DNA methylation signatures of Prostate Cancer in peripheral T-cells. Bmc Cancer. 20: 588
Mahmood N, Arakelian A, Khan HA, et al. (2020) uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions. Bone Research. 8: 18
Mehdi A, Attias M, Mahmood N, et al. (2020) Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma Frontiers in Oncology. 10
See more...